- March 15, 2022
- Newsletter
- 617-430-5616
Menu
Brand Name :
Zomig, Zomig-ZMT
Synonyms :
zolmitriptan
Class :
Antimigraine agent, Serotonine 5-HT1b,1D receptor agonist
Dosage Forms & Strengths
Solution, Nasal:
2.5 mg
5 mg
Tablet, Oral:
2.5 mg
5 mg
Tablet disintegrating, Oral:
2.5 mg
5 mg
5 - 10
mg
at the beginning of cluster headache (max. 10 mg)
2.5
mg
Oral
Tablet
2 to 3 times a day, 2 days before the onset of menses and continue for around 7 days
No safe and efficacious dose described
Refer to adult dosing
may have an increasingly adverse effect when combined with serotonin 5-HT1D receptor agonists
may increase the risk of hypertension when combined
may enhance the vasoconstricting effect of ergot Derivatives
may enhance the vasoconstricting effect of ergot Derivatives
may enhance the vasoconstricting effect of ergot Derivatives
may enhance the vasoconstricting effect of ergot Derivatives
may enhance the vasoconstricting effect of ergot Derivatives
may enhance the serotonergic effect of monoamine oxidase inhibitors
may enhance the serotonergic effect of monoamine oxidase inhibitors
may enhance the serotonergic effect of monoamine oxidase inhibitors
may enhance the serotonergic effect of monoamine oxidase inhibitors
may enhance the serotonergic effect of monoamine oxidase inhibitors
may have an increased vasoconstricting effect when combined with ergot derivatives
may have an increased vasoconstricting effect when combined with ergot derivatives
may have an increased vasoconstricting effect when combined with ergot derivatives
may have an increased vasoconstricting effect when combined with ergot derivatives
may have an increased vasoconstricting effect when combined with ergot derivatives
may have an increased vasoconstricting effect when combined with ergot derivatives
may have an increased vasoconstricting effect when combined with ergot derivatives
may have an increased serotonergic effect when combined with monoamine oxidase inhibitors
may have an increased serotonergic effect when combined with monoamine oxidase inhibitors
may have an increased serotonergic effect when combined with monoamine oxidase inhibitors
may have an increased serotonergic effect when combined with monoamine oxidase inhibitors
may have an increased serotonergic effect when combined with monoamine oxidase inhibitors
may have an increasingly adverse effect when combined with sumatriptan
serotonin 5-HT1D receptor agonists increase the serotonergic effect of MAO inhibitors
may have an increased serotonergic effect when combined with serotonergic agents
may enhance the serotonergic effect of serotonergic agents
may enhance the risk or severity of hypertension when combined
may enhance the risk or severity of hypertension when combined
may increase the risk or severity of hypertension when combined
may have an increased hypertensive effect when combined with droxidopa
may increase the vasoconstricting effect of Serotonin 5-HT1D Receptor Agonists
Frequency defined:
>10% (significant)
Coronary vasospasm
Angina pectoris
Peripheral vascular ischemia
Splenic infarction
Heaviness
1% to 10%
Elevated blood pressure
Vomiting
Dry mouth
Abdominal pain
Muscle weakness
Warm sensation
Cardiac rhythm disturbance
Cardiac arrest
Stroke
Pregnancy consideration: zolmitriptan is unsafe for pregnant women to use and it is assigned under category C.
Lactation: excretion of zolmitriptan in breast milk is not known.
Pregnancy category:
Patient information leaflet
Generic Name: Zolmitriptan
Pronounced: zolmitriptan
Why do we use zolmitriptan?
Zolmitriptan is used for the treatment of cluster and migraine headaches.